External perspectives from pharma, academia, clinical research and core facilities on moving proteomics from discovery toward quantitative confidence.
ProteomEdge works with scientists across pharma, academia, clinical research and core facilities to make targeted mass spectrometry-based protein quantification more robust, scalable and accessible. In this series, external voices share how multiplexed qRePS-supported workflows can help move proteomics from discovery toward quantitative confidence.
How low-load testing of qRePS is informing the development of internal standards for single-cell and spatial proteomics.
How targeted proteomics and qRePS-supported quantification can support reproducible plasma biomarker validation across cohorts and research into more individualized thrombosis risk assessment.
How combining discovery proteomics, targeted workflows and qRePS-supported quantification can improve robustness when investigating liver disease biology and biomarker candidates across cohorts.
A core facility perspective on lowering the barrier to robust, multiplexed absolute protein quantification for researchers across life science, translational research and precision medicine.
How absolute apolipoprotein quantification can help pharma teams generate reproducible protein data across studies and explore biology that conventional lipid readouts miss.
Explore our validated qRePS™ panels or get in touch with our team to discuss customized targeted mass spectrometry solutions for your study.